Promising Results of Zika Vaccine: Preclinical Efficacy Insights
A Zika virus vaccine candidate demonstrates efficacy in preventing vertical transmission from mother to fetus in preclinical animal studies, offering promising prospects for Zika virus prevention and control strategies in human populations.
October 2022
Neurological Developmental Differences in Infants Born During the COVID-19 Pandemic
Being born during the COVID-19 pandemic is associated with differences in neurological development at 6 months of age, suggesting potential impacts of prenatal and early-life exposures on infant brain development and highlighting the need for further research to understand the long-term consequences.
October 2022
Congenital Pigmentary Anomalies in Neonates: Clinical Updates and Management
An update on manifestations, diagnosis, and treatment of neonatal congenital pigment anomalies provides valuable insights into the identification and management of these dermatological conditions in newborns, facilitating timely interventions and improved outcomes.
September 2022
Impact of Poverty Reduction on Children’s Brain Activity: Neurodevelopmental Insights
Unconditional cash transfers to mothers living in poverty during their children’s first year of life can lead to changes in babies’ brain activity, highlighting the potential neurodevelopmental benefits of poverty reduction interventions in early childhood.
September 2022
Biomarker Validation in Muscle-Invasive Bladder Cancer: Prospective Trial Insights
The first prospective, randomized biomarker validation trial in patients with muscle-invasive bladder cancer treated with chemotherapy provides valuable insights into the clinical utility of biomarkers for prognostication and treatment response prediction, informing personalized management strategies for this aggressive malignancy.
September 2022
COVID-19 Vaccine Safety in Pregnancy: Reassuring Data from Observational Studies
Reassuring data from observational studies support the safety of the COVID-19 vaccine during pregnancy, providing important insights for pregnant individuals and healthcare providers regarding vaccination decisions and maternal-fetal health outcomes.
September 2022
Breastfeeding Reduces Cardiovascular Risk in Mothers: Study Findings
Women who breastfeed have an 11% lower risk of developing cardiovascular disease, highlighting the cardiovascular benefits of breastfeeding and underscoring the importance of promoting and supporting breastfeeding practices.
September 2022
Antiphospholipid Syndrome: Vascular Thrombosis and Pregnancy Complications
Antiphospholipid syndrome is a systemic autoimmune disease characterized by vascular thrombosis or pregnancy complications associated with antiphospholipid antibodies, emphasizing the need for multidisciplinary management and risk stratification.
June 2022
Maternal Vitamin D Levels and Autism Spectrum Disorder Risk: Implications for Prenatal Care
Association between low maternal 25(OH)D levels during pregnancy and elevated risk of autism spectrum disorder in offspring underscores the importance of prenatal vitamin D supplementation and early intervention strategies.
June 2022
